Literature DB >> 14663145

Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon.

Nobuyuki Shimono1, Lisa Morici, Nicola Casali, Sally Cantrell, Ben Sidders, Sabine Ehrt, Lee W Riley.   

Abstract

An estimated one-third of the world's population is latently infected with Mycobacterium tuberculosis, the etiologic agent of tuberculosis. Here, we demonstrate that, unlike wild-type M. tuberculosis, a strain of M. tuberculosis disrupted in the mce1 operon was unable to enter a stable persistent state of infection in mouse lungs. Instead, the mutant continued to replicate and killed the mice more rapidly than did the wild-type strain. Histological examination of mouse lungs infected with the mutant strain revealed diffusely organized granulomas with aberrant inflammatory cell migration. Murine macrophages infected ex vivo with the mutant strain were reduced in their ability to produce tumor necrosis factor alpha, IL-6, monocyte chemoattractant protein 1, and nitric oxide (NO), but not IL-4. The mce1 mutant strain complemented with the mce1 genes stimulated tumor necrosis factor alpha and NO production by murine macrophages at levels stimulated by the wild-type strain. These observations indicate that the mce1 operon mutant is unable to stimulate T helper 1-type immunity in mice. The hypervirulence of the mutant strain may have resulted from its inability to stimulate a proinflammatory response that would otherwise induce organized granuloma formation and control the infection without killing the organism. The mce1 operon of M. tuberculosis may be involved in modulating the host inflammatory response in such a way that the bacterium can enter a persistent state without being eliminated or causing disease in the host.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14663145      PMCID: PMC307668          DOI: 10.1073/pnas.2433882100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement.

Authors:  T Parish; N G Stoker
Journal:  Microbiology       Date:  2000-08       Impact factor: 2.777

2.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta.

Authors:  C Manca; L Tsenova; A Bergtold; S Freeman; M Tovey; J M Musser; C E Barry; V H Freedman; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.

Authors:  D M Underhill; A Ozinsky; K D Smith; A Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

4.  Invasion activity of a Mycobacterium tuberculosis peptide presented by the Escherichia coli AIDA autotransporter.

Authors:  Nicola Casali; Marc Konieczny; M Alexander Schmidt; Lee W Riley
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  Mycobacterium tuberculosis signal transduction system required for persistent infections.

Authors:  T C Zahrt; V Deretic
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

6.  Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.

Authors:  J D McKinney; K Höner zu Bentrup; E J Muñoz-Elías; A Miczak; B Chen; W T Chan; D Swenson; J C Sacchettini; W R Jacobs; D G Russell
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

7.  Restraining mycobacteria: role of granulomas in mycobacterial infections.

Authors:  B M Saunders; A M Cooper
Journal:  Immunol Cell Biol       Date:  2000-08       Impact factor: 5.126

8.  Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis.

Authors:  Tanya Parish; Debbie A Smith; Sharon Kendall; Nicola Casali; Gregory J Bancroft; Neil G Stoker
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

9.  Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology.

Authors:  V P Mohan; C A Scanga; K Yu; H M Scott; K E Tanaka; E Tsang; M M Tsai; J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

10.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

Authors:  V Kindler; A P Sappino; G E Grau; P F Piguet; P Vassalli
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

View more
  90 in total

1.  An adjunctive therapeutic vaccine against reactivation and post-treatment relapse tuberculosis.

Authors:  Toshiko Miyata; Chan-Ick Cheigh; Nicola Casali; Amador Goodridge; Olivera Marjanovic; Lon V Kendall; Lee W Riley
Journal:  Vaccine       Date:  2011-11-08       Impact factor: 3.641

2.  Vaccination of guinea pigs using mce operon mutants of Mycobacterium tuberculosis.

Authors:  Andrés Obregón-Henao; Crystal Shanley; María Verónica Bianco; Angel A Cataldi; Randall J Basaraba; Ian M Orme; Fabiana Bigi
Journal:  Vaccine       Date:  2011-04-22       Impact factor: 3.641

3.  The renaissance of continuous culture in the post-genomics age.

Authors:  Alan T Bull
Journal:  J Ind Microbiol Biotechnol       Date:  2010-09-11       Impact factor: 3.346

4.  An orphaned Mce-associated membrane protein of Mycobacterium tuberculosis is a virulence factor that stabilizes Mce transporters.

Authors:  Ellen Foot Perkowski; Brittany K Miller; Jessica R McCann; Jonathan Tabb Sullivan; Seidu Malik; Irving Coy Allen; Virginia Godfrey; Jennifer D Hayden; Miriam Braunstein
Journal:  Mol Microbiol       Date:  2016-02-05       Impact factor: 3.501

5.  Comparative metabolic profiling of mce1 operon mutant vs wild-type Mycobacterium tuberculosis strains.

Authors:  Adriano Queiroz; Daniel Medina-Cleghorn; Olivera Marjanovic; Daniel K Nomura; Lee W Riley
Journal:  Pathog Dis       Date:  2015-08-28       Impact factor: 3.166

6.  Characterization of mycobacterial virulence genes through genetic interaction mapping.

Authors:  Swati M Joshi; Amit K Pandey; Nicole Capite; Sarah M Fortune; Eric J Rubin; Christopher M Sassetti
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-25       Impact factor: 11.205

Review 7.  Genetics-squared: combining host and pathogen genetics in the analysis of innate immunity and bacterial virulence.

Authors:  Jenny Persson; Russell E Vance
Journal:  Immunogenetics       Date:  2007-09-14       Impact factor: 2.846

8.  The actinobacterial mce4 locus encodes a steroid transporter.

Authors:  William W Mohn; Robert van der Geize; Gordon R Stewart; Sachi Okamoto; Jie Liu; Lubbert Dijkhuizen; Lindsay D Eltis
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

9.  Mce2 operon mutant strain of Mycobacterium tuberculosis is attenuated in C57BL/6 mice.

Authors:  Olivera Marjanovic; Toshiko Miyata; Amador Goodridge; Lon V Kendall; Lee W Riley
Journal:  Tuberculosis (Edinb)       Date:  2009-12-05       Impact factor: 3.131

10.  Serum anti-Mce1A immunoglobulin detection as a tool for differential diagnosis of tuberculosis and latent tuberculosis infection in children and adolescents.

Authors:  Christiane M Schmidt; Kathryn L Lovero; Fabiana R Carvalho; Daniele C M Dos Santos; Ana Cláudia M W Barros; Ana Paula Quintanilha; Ana Paula Barbosa; Marcos V S Pone; Sheila M Pone; Julienne Martins Araujo; Camila de Paula Martins; Solange G D Macedo; Ana Lúcia Miceli; Maria Luíza Vieira; Selma M A Sias; Adriano Queiroz; Luis Guillermo Coca Velarde; Afranio L Kritski; Andrea A Silva; Clemax C Sant'Anna; Lee W Riley; Claudete A Araújo Cardoso
Journal:  Tuberculosis (Edinb)       Date:  2019-12-05       Impact factor: 3.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.